Paolo Maggi to Middle Aged
This is a "connection" page, showing publications Paolo Maggi has written about Middle Aged.
Connection Strength
0.084
-
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. BMC Infect Dis. 2019 Jun 25; 19(1):555.
Score: 0.013
-
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018 02; 83(2):283-294.
Score: 0.012
-
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort. Atherosclerosis. 2017 08; 263:398-404.
Score: 0.011
-
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients. In Vivo. 2017 01 02; 31(1):125-131.
Score: 0.011
-
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS One. 2020; 15(12):e0243700.
Score: 0.004
-
Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
Score: 0.004
-
Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord. 2020 08 14; 20(1):373.
Score: 0.004
-
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021 Mar; 268(3):751-757.
Score: 0.004
-
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy. J Am Heart Assoc. 2020 09; 9(17):e016948.
Score: 0.004
-
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care. 2020 07; 43(7):1408-1415.
Score: 0.004
-
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
Score: 0.003
-
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience. J Women Aging. 2019 Mar-Apr; 31(2):176-188.
Score: 0.003
-
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
Score: 0.003
-
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens. 2017 02; 35(2):409-416.
Score: 0.003
-
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients. Dig Liver Dis. 2017 May; 49(5):530-534.
Score: 0.003